Search Results - "Laptev, Dmitry N."

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring by Tauschmann, Martin, Forlenza, Gregory, Hood, Korey, Cardona‐Hernandez, Roque, Giani, Elisa, Hendrieckx, Christel, DeSalvo, Daniel J., Laffel, Lori M., Saboo, Banshi, Wheeler, Benjamin J., Latpev, Dmitry N., Yarhere, Iroro, DiMeglio, Linda A.

Get full text

Use of telemedicine improves glycemic control and quality of life in type 1 diabetes children on insulin pump therapy by Laptev, Dmitry N., Peterkova, Valentina A.

“…Rationale: Healthcare access plays a significant role in the improvement and maintaining of glycemic control and quality of life in type 1 diabetes mellitus…”
Get full text

Severe Wolcott-Rallison syndrome due to a nonsense mutation in the first exon EIF2AK3 by Gubaeva, Diliara N., Laptev, Dmitry N., Tiulpakov, Anatoly N., Petrova, Lidia M.

“…Wolcott-Rallison syndrome is a rare autosomal recessive disease characterized by neonatal diabetes mellitus in combination with osteodysplasia and liver…”
Get full text

Resolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy by Antsiferov, Mikhail B., Galstyan, Gagik R., Zilov, Alexey V., Mayorov, Alexander Y., Markova, Tatyana N., Demidov, Nikolay A., Koteshkova, Olga M., Laptev, Dmitry N., Vitebskaya, Alisa V.

“…The Scientific Advisory Board, chaired by Professor G. R. Galstyan (cochair - A.V. Zilov), met in Moscow on 19 June 2018 to discuss the possibilities of…”
Get full text

Diabetes mellitus type 1 in childhood by Peterkova, Valentina A., Shestakova, Marina V., Bezlepkina, Olga B., Laptev, Dmitry N., Kuraeva, Tamara L., Mayorov, Aleksandr Y., Titovich, Elena V., Emelyanov, Andrey O., Svetlova, Galina N., Eremina, Irina Aleksandrovna, Alimova, Irina L., Bashnina, Elena B., Bolotova, Nina V., Galkina, Galina A., Kostrova, Irina B., Мalievsky, Oleg A., Petriaikina, Elena E., Samsonova, Lubov N., Khramova, Elena B.

“…Public organization "Russian Association of Endocrinologists". Clinical guidlines…”
Get full text

Free-living use of artificial pancreas for children with type 1 diabetes: systematic review by Dovc, Klemen, Mutlu, Gül Yeşiltepe, Philippov, Yury I., Laptev, Dmitry N., Patrakeeva, Evgenia M., Chernilova, Lubov O., Zalevskaya, Alsu G., Shestakova, Marina V., Battelino, Tadej

“…BACKGRAUND: A closed-loop glucose control system or artificial pancreas consists of three components a Continuous Glucose Monitor (CGM), infusion pumps to…”
Get full text

Diabetes mellitus in children and adolescents according to the Federal diabetes registry in the Russian Federation: dynamics of major epidemiological characteristics for 2013–2016 by Dedov, Ivan I., Shestakova, Marina V., Peterkova, Valentina A., Vikulova, Olga K., Zheleznyakova, Anna V., Isakov, Mikhail А., Laptev, Dmitry N., Andrianova, Ekaterina A., Shiryaeva, Tatyana Y.

“…Background: The data of the register is the main source of up-to-date information about patients with diabetes mellitus (DM). Its very important for improving…”
Get full text

Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 9th edition by Dedov, Ivan I., Shestakova, Marina V., Mayorov, Aleksandr Y., Vikulova, Olga K., Galstyan, Gagik R., Kuraeva, Tamara L., Peterkova, Valentina A., Smirnova, Olga M., Starostina, Elena G., Surkova, Elena V., Sukhareva, Olga Y., Tokmakova, Alla Y., Shamkhalova, Minara S., Jarek-Martynova, Ivona Renata, Artemova, Ekaterina V., Beshlieva, Diana D., Bondarenko, Olga N., Volevodz, Natalya N., Grigoryan, Olga R., Gomova, Irina S., Dzhemilova, Zera N., Esayan, Roza M., Ibragimova, Liudmila I., Kalashnikov, Viktor Y., Kononenko, Irina V., Laptev, Dmitry N., Lipatov, Dmitry V., Motovilin, Oleg G., Nikonova, Tatiana V., Rozhivanov, Roman V., Shestakova, Ekaterina A.

“…Dear Colleagues! We are glad to present the 9th Edition (revised) of Standards of Diabetes Care. These evidence-based guidelines were designed to standardize…”
Get full text

The Identification of a Novel Pathogenic Variant in the GATA6 Gene in a Child with Neonatal Diabetes by Sechko, Elena A., Koltakova, Maria P., Khusainova, Rita I., Minniakhmetov, Ildar R., Laptev, Dmitry N.

“…GATA6 syndrome is a rare monogenic disorder caused by heterozygous variants in the gene GATA6, which controls the early embryonic differentiation of germ…”
Get full text

Non-commercial insulin delivery closed-loop systems by Sorokin, Daniil Iu, Laptev, Dmitry N.

Get full text

Towards prevention of type 1 diabetes: FDA approved first drug with potential to delay clinical stage of disease by Laptev, D. N., Dedov, I. I.

“…Given the increased morbidity and mortality in patients with type 1 diabetes mellitus (T1DM), as well as the burden posed by the disease, the search for…”
Get full text

Diabetes mellitus associated with type A insulin resistance by Sechko, E. A., Kuraeva, T. L., Peterkova, V. A., Laptev, D. N.

“…Insulin resistance type A is a monogenic disorder with insulin action defect, observed in females with acanthosis nigricans (AN), hyperandrogenism,…”
Get full text

Clinical decision support system based on artificial intelligence for adjusting insulin pump parameters in children with type 1 diabetes mellitus by Sorokin, D. Yu, Trufanova, E. S., Rebrova, O. Yu, Bezlepkina, O. B., Laptev, D. N.

“…BACKGROUND: Widely available diabetes devices (continuous glucose monitoring, insulin pump etc.) generate large amount of data and development of an advanced…”
Get full text

Effectiveness and safety of an artificial intelligence-based medical decision support system for adjusting insulin pump settings in children with type 1 diabetes mellitus: randomized controlled trial by Laptev, D. N., Sorokin, D. Yu, Trufanova, E. S., Rebrova, O. Yu, Bezlepkina, O. B.

“…BACKGROUND: Previously, we presented the process of developing a clinical decision support system (CDSS) for adjusting insulin pump (IP) settings in children…”
Get full text

Clinical prediction model for MODY type diabetes mellitus in children by Laptev, D. N., Sechko, E. A., Romanenkova, E. M., Eremina, I. A., Bezlepkina, O. B., Peterkova, V. A., Mokrysheva, N. G.

“…BACKGROUND: MODY (maturity-onset diabetes of the young) is a rare monogenic form of diabetes mellitus, the gold standard of diagnosis is mutations detection in…”
Get full text

Islet autoantibodies and residual beta-cell function in children with type 1 diabetes depending on age of manifestation by Romanenkova, E. M., Zufarova, I. M., Sorokin, D. Y., Eremina, I. A., Sechko, E. A., Nikankina, L. V., Peterkova, V. A., Bezlepkina, O. B., Laptev, D. N.

“…BACKGROUND : Type 1 diabetes mellitus (T1D) is an autoimmune disorder that leads to pancreatic β-cells destruction and progressive decrease of insulin…”
Get full text

Non-immune diabetes mellitus in children due to heterozygous mutations in the glucokinase gene (GCK-MODY): data of 144 patients by Sechko, E. A., Kuraeva, T. L., Zilberman, L. I., Laptev, D. N., Bezlepkina, O. B., Peterkova, V. A.

“…BACKGROUND: Monogenic diabetes mellitus (MDM) is a rare form of diabetes mellitus (DM) which caused by one or more mutations in one of the genes that cause…”
Get full text

The role of specific pancreatic antibodies in the differential diagnosis of complete clinical and laboratory remission of type 1 diabetes mellitus and MODY in children by Sechko, E. A., Romanenkova, E. M., Eremina, I. A., Zilberman, L. I., Nikankina, L. V., Zuraeva, Z. T., Bezlepkina, O. B., Peterkova, V. A., Laptev, D. N.

“…BACKGROUND: T1D is characterized by autoimmune destruction of pancreatic β-cells, which develops due to genetic and environmental risk factors. Shortly after…”
Get full text

MODY caused by a mutation in the insulin gene by Sechko, E. A., Kuraeva, T. L., Andrianova, E. A., Zilberman, L. I., Emelyanov, A. O., Laptev, D. N., Bezlepkina, O. B.

“…MODY10 is a rare subtype of MODY diabetes, which caused by heterozygous mutations in the insulin gene INS. There are single descriptions of families with…”
Get full text

Remote monitoring of adolescents with type 1 diabetes mellitus using a mobile application by Laptev, D. N., Eremina, I. A., Karpushkina, A. V., Petryaykina, E. E., Bezlepkina, O. B., Peterkova, V. A.

“…Background: The prevalence of type 1 diabetes mellitus (T1DM) in childhood is increasing every year. Adolescence is the most challenging age for achieving…”
Get full text